About Medicine by Design

This author has not yet filled in any details.
So far Medicine by Design has created 15 blog entries.

People of Medicine by Design: Dr. Phyllis Billia

"I’m really interested in understanding why and how the heart fails, and how we can help the heart to regenerate itself. As a cardiologist who looks after patients with end-stage heart failure waiting for heart transplants and mechanical hearts, it’s really important to me to think outside the box about these questions."

By |2021-01-11T21:40:21-05:00December 17th, 2020|Categories: News, People of Medicine by Design|Tags: , |

Mapping out the mystery of blood stem cells

Using state-of-the art sequencing technology, Medicine by Design-funded scientists have revealed how stem cells are able to generate new blood cells throughout our life, and how these same cellular mechanisms can evade chemotherapy to survive and cause relapse many years later.

By |2020-11-25T17:16:40-05:00November 25th, 2020|Categories: News, Research|Tags: , , |

People of Medicine by Design: Khalid Al-Zahrani

"What’s exciting to me is the development of new bio-informatic tools, and the interface of computational biology with basic science. The sky is the limit to what we can do now, even compared to when I was PhD student. We can re-ask questions that were asked in the 1990s or 2000s, or even the 2010s, and answer them in a different light."

By |2020-12-18T10:17:54-05:00October 23rd, 2020|Categories: People of Medicine by Design|

People of Medicine by Design: Ashton Trotman-Grant

"I have two main ambitions. I want to democratize medicine so all these amazing breakthroughs in regenerative medicine, immunotherapy and synthetic biology are accessible to communities that need them. I also want to inspire a diverse generation of young people to pursue science and entrepreneurship."

By |2020-12-18T10:21:37-05:00October 23rd, 2020|Categories: People of Medicine by Design|

Medicine by Design-funded team uses stem cells to grow functional blood vessel cells found in the liver

Discovery to provide insights into liver development and disease progression

Researchers delay onset of amyotrophic lateral sclerosis (ALS) in laboratory models

A team of researchers led by scientists at the University of Toronto has delayed the onset of amyotrophic lateral sclerosis (ALS) in mice. They are cautiously optimistic that this research, which was funded in part by a Medicine by Design 2018 New Ideas Award, combined with other clinical advances, points to a potential treatment for ALS in humans.

By |2020-04-24T16:19:27-04:00April 22nd, 2020|Categories: News|Tags: , , , |
Go to Top